MedPath

Unity Health Toronto

Unity Health Toronto logo
🇨🇦Canada
Ownership
Private
Established
2017-01-01
Employees
10K
Market Cap
-
Website
http://www.unityhealth.to

Canadian Sudden Cardiac Arrest Network

Completed
Conditions
Sudden Cardiac Arrest
Sudden Cardiac Death
Interventions
Other: There is no intervention in this study.
First Posted Date
2018-08-22
Last Posted Date
2024-01-11
Lead Sponsor
Unity Health Toronto
Target Recruit Count
82054
Registration Number
NCT03642587
Locations
🇨🇦

Alberta Health Services, Calgary, Alberta, Canada

🇨🇦

Emergency Health Services, Halifax, Nova Scotia, Canada

🇨🇦

University of British Columbia, Vancouver, British Columbia, Canada

and more 3 locations

Decision Support Intervention Adapted for HIV Pre-Exposure Prophylaxis for Adoption and Adherence for Black Canadians

Not Applicable
Conditions
HIV/AIDS
Interventions
Behavioral: Decision Support Aid and PrEP for Black Canadians
First Posted Date
2018-08-17
Last Posted Date
2019-04-12
Lead Sponsor
Unity Health Toronto
Target Recruit Count
90
Registration Number
NCT03637244
Locations
🇨🇦

St. Michael's Hospital Academic Family Health Team, Toronto, Ontario, Canada

BEFORE Decision Aid Implementation Study

Not Applicable
Conditions
Young Adult
Breast Neoplasm Female
Decision Support Techniques
Evaluation Studies
Interventions
Behavioral: BEFORE decision aid
First Posted Date
2018-08-14
Last Posted Date
2018-08-14
Lead Sponsor
Unity Health Toronto
Target Recruit Count
224
Registration Number
NCT03629509
Locations
🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

Modafinil's Effects on Cognition in Remitted MDD

Phase 3
Terminated
Conditions
Cognitive Impairment
Major Depressive Disorder
Interventions
Drug: Placebo
Drug: Modafinil
First Posted Date
2018-08-08
Last Posted Date
2019-08-08
Lead Sponsor
Unity Health Toronto
Target Recruit Count
9
Registration Number
NCT03620253
Locations
🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

Incidental Genomics

Not Applicable
Active, not recruiting
Conditions
Cancer
Interventions
Other: Incidental Genomic Sequencing Results
Other: GS Results for Primary Indications only
First Posted Date
2018-07-24
Last Posted Date
2023-12-06
Lead Sponsor
Unity Health Toronto
Target Recruit Count
289
Registration Number
NCT03597165
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

🇨🇦

Princess Margret Cancer Centre, Toronto, Ontario, Canada

🇨🇦

Sunnybrook Hospital, Toronto, Ontario, Canada

Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome

Not Applicable
Terminated
Conditions
Alcohol Withdrawal Seizures
Alcohol Withdrawal Delirium
Alcohol Withdrawal
Interventions
Drug: Phenobarbital Sodium
Drug: Inactive placebo
First Posted Date
2018-07-13
Last Posted Date
2023-11-02
Lead Sponsor
Unity Health Toronto
Target Recruit Count
8
Registration Number
NCT03586089
Locations
🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

Neural Correlates of Driving and Cannabis

Phase 1
Conditions
Cannabis Use
Driving Impaired
Interventions
First Posted Date
2018-07-10
Last Posted Date
2020-03-23
Lead Sponsor
Unity Health Toronto
Target Recruit Count
12
Registration Number
NCT03581058
Locations
🇨🇦

University Health Network, Toronto, Ontario, Canada

Characterizing Dopamine Receptor Binding in Treatment Resistant Depression

Not yet recruiting
Conditions
Treatment Resistant Depression
Interventions
Diagnostic Test: PET scans
First Posted Date
2018-05-25
Last Posted Date
2024-08-20
Lead Sponsor
Unity Health Toronto
Target Recruit Count
45
Registration Number
NCT03537794

Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia

Phase 2
Terminated
Conditions
Knee Arthropathy
Anemia of Chronic Disease
Hip Arthropathy
Anemia, Iron Deficiency
Interventions
Drug: Iron sucrose
Drug: Placebo
Drug: Epoetin Alfa
First Posted Date
2018-05-18
Last Posted Date
2021-06-18
Lead Sponsor
Unity Health Toronto
Target Recruit Count
4
Registration Number
NCT03528564
Locations
🇨🇦

St. Michael's Hosptial, Toronto, Ontario, Canada

Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia

Phase 3
Conditions
Immune Thrombocytopenia
Interventions
Drug: Placebo
Drug: Oseltamivir
First Posted Date
2018-05-09
Last Posted Date
2020-10-22
Lead Sponsor
Unity Health Toronto
Target Recruit Count
30
Registration Number
NCT03520049
Locations
🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath